What's inside Elon's building in Memphis will shock you

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.

Anavex Life Sciences Corporation
NASDAQ:AVXL
$11.20

Financials

Curr Year EPS Estimate-0.56
Next Quarter EPS Estimate-0.17
Return on Assets-0.25
Return on Equity-0.40
Earnings Per Share-0.56

General

NameAnavex Life Sciences Corporation
TickerAVXL
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndSeptember
Full Time Employees42

About Anavex Life Sciences Corporation

Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in the development of novel therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsychiatric disorders, including Alzheimer's disease, Parkinson's disease, schizophrenia, Rett syndrome, and other central nervous system (CNS) diseases, pain, and various types of cancer. Its lead drug candidate, ANAVEX 2-73 (blarcamesine), which has completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease; a Phase 2 proof-of-concept study in Parkinson's disease dementia; and a Phase 2 and a Phase 3 study in adult patients and one Phase 2/3 study in pediatric patients with Rett syndrome. Its ANAVEX 2-73 is an orally available drug candidate designed to restore cellular homeostasis by targeting SIGMAR1 and muscarinic receptors. The ANAVEX 2-73 also exhibited anticonvulsant, anti-amnesic, neuroprotective, and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy. The company's ANAVEX 3-71, which targets SIGMAR1 and M1 muscarinic receptors, is a clinical stage drug candidate demonstrating disease-modifying activity against the Alzheimer's disease in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid, and tau pathologies. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.

Earnings

Popular

Jim Cramer Recommends This 'Really, Really Good' Energy Stock

Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.

These 3 Dividend-Yielding Stocks Could Outperform As High Fed Rates Spark $4.9 Billion Inflows: Expert

Expert highlights the top high divided yielding stocks and funds that investors could consider to seize the opportunity amid high Fed rates.

Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad

The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.

Apple Surges After-Hours As Q3 Earnings Crush Estimates, iPhone And Services Lead Growth

Apple Inc. shares jumped 2.42% in after-hours trading on Thursday, reaching $212.59, after the iPhone maker delivered third-quarter results that significantly exceeded Wall Street expectations.

Trump, Powell Clash Over $3 Billion Federal Reserve Renovations In Front Of Reporters

President Trump and Fed Chair Jerome Powell have a public disagreement on Thursday at the Federal Reserve building.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

From tech podcasts to policy: Trump's new AI plan leans heavily on Silicon Valley industry ideas

An artificial intelligence agenda that started coalescing on the podcasts of is now being forged into U.S. policy as President Donald Trump leans on the ideas of the who backed his election campaign.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Questions emerge about NYC gunman's mental health and his security-sensitive job in Las Vegas

LAS VEGAS (AP) — The man who stormed a Manhattan office tower with a gun, before killing himself, worked in the surveillance department of a Las Vegas casino, part of an industry built on watching for threats before they unfold.

Want To Bet Bigger On UnitedHealth? Now There's A Cheaper Way

New UNHG ETF offers 200% daily exposure to UnitedHealth Group with low expense ratio. Themes ETFs adds to roster with 20 single-stock leveraged ETFs.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Trump to visit Federal Reserve headquarters as feud with its chair continues

WASHINGTON (AP) — President Donald Trump is visiting the Federal Reserve headquarters in Washington Thursday, a week after indicating that Fed chair Jerome Powell's on two Fed buildings could be grounds for firing.

Cathie Wood Goes On A $20M Bitmine Immersion Bargain Hunt As Ark Trims Robinhood And Palantir Stakes

On Monday, Cathie Wood-led Ark Invest made significant trades, including a notable purchase of Bitmine Immersion Technologies Inc. (BMNR) shares.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Charles Schwab To Launch Bitcoin, Ethereum Trading Services

Charles Schwab (NYSE:SCHW), one of the largest brokerage firms in the United States, has confirmed plans to launch Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO:

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Why Is Donald Trump Ignoring Elon Musk's Call For 'Phase 2' Of The Epstein Files?

Musk's post questioning Trump's unfulfilled promise of Epstein-related disclosures reignites tensions over transparency in politics and tech.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

XPO Cuts Costs, Expands Margins Despite Freight Slowdown

XPO, Inc. (NYSE: XPO) reported Q2 2025 financial results, with adjusted EPS of $1.05 beating analyst consensus. Revenue was $2.08B, slightly above estimates. North American LTL segment showed strong operational performance.

Li Auto Debuts Li i8 Electric SUV With Ultra-Fast Charging

Li Auto launches Li i8 six-seat battery electric SUV, expanding EV lineup. Features advanced safety systems, fast charging, and AI-powered agent.

If You Missed Tesla, Here's Your "Second Chance"... - Ad

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

Russia insists on achieving Ukraine goals despite Trump's ultimatum

Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .

Meta's AI Firepower Could Ignite Magnificent Seven ETFs

Meta Platformsis expected to report its 11th consecutive revenue beat, attracting attention from stock pickers and ETF investors due to its growing presence in Big Tech and AI-themed ETFs.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

FOMC Meeting Preview: Will Jerome Powell Accelerate The Bitcoin, Ethereum, XRP Bull Run?

Bitcoin (CRYPTO: BTC) and other cryptocurrencies continue to trade sideways ahead of Wednesday’s Federal Open Market Committee meeting, though pundits expect volatility to pick up soon.

Fire is still burning at a Nebraska biofuels plant where explosion left 3 missing

FREMONT, Neb. (AP) — Fire and heavy smoke were still pouring out of a Nebraska biofuels plant Wednesday morning, preventing firefighters from getting close enough to search for a day earlier, officials said.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.

Sony's Chipset Unit Up For Sale To Fuel Entertainment Push

Sony is selling its cellular chipset unit as it focuses on entertainment. The unit, acquired for $212M in 2016, could be worth $300M.

How high-tech tools, and pigs, could help in the search for Mexican drug cartel victims

ZAPOPAN, Mexico (AP) — First the scientists dress dead swine in clothes, then they dispose of the carcasses. Some they wrap in packing tape, others they chop up. They stuff the animals into plastic bags or wrap them in blankets. They cover them in lime or burn them. Some are buried alone, others in groups.

Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad

The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.

A Turkish Airlines flight is evacuated via emergency slides after smoke detected in landing gear

ANKARA, Turkey (AP) — A Turkish Airlines flight was evacuated via emergency slides shortly after landing Tuesday at a coastal resort in southern because of smoke in the landing gear, officials said. There were no injuries.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

Can Apple's Slim iPhone And Cheaper Macs Reverse The 2025 Stock Slump?

Apple is expected to rebound in the second half of 2025 with new product launches and strong momentum in its Services division. Analysts reaffirmed a Buy rating with a price forecast of $235.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Drone attacks on oil fields in Iraq's Kurdish region shut down another facility

BAGHDAD (AP) — Drones targeted Wednesday, the latest in a series of attacks in recent days that have put several oil facilities out of commission.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service